STE vs STRO
STERIS plc (STE) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
STERIS plc (STE) is a medical devices company listed on NYSE.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported STE revenue for 2025-03-31 was $5.46B. Net income was $616.1M. Revenue was up 284.6% from 2024-03-31 to 2025-03-31. STE currently screens at market cap $19.43B and trailing P/E 25.1.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
STE currently screens at market cap $19.43B and trailing P/E 25.1. STRO currently screens at market cap $470.8M.
Not investment advice. Open the STE and STRO stock pages for the full models.
Not investment advice.